A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality

…, A Muñoz-Gómez, A Sancho-López… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Evidence to support the use of steroids in coronavirus disease 2019 (COVID-19) pneumonia
is lacking. We aim to determine the impact of steroid use for COVID-19 pneumonia on …

[HTML][HTML] Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study

B Ruiz-Antorán, A Sancho-López, F Torres… - Infectious diseases and …, 2021 - Springer
Background We aimed to determine the impact of tocilizumab use on severe COVID-19 (coronavirus
disease 19) pneumonia mortality. Methods We performed a multicentre …

[HTML][HTML] Efficacy and safety of sarilumab in patients with COVID19 pneumonia: a randomized, phase III clinical trial (SARTRE study)

A Sancho-López, AF Caballero-Bermejo… - Infectious diseases and …, 2021 - Springer
Introduction SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The
cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-…

Impact of glucocorticoid treatment in SARS-CoV-2 infection mortality: a retrospective controlled cohort study

…, B Ruiz-Antoran, AM Gómez, A Sancho López… - medRxiv, 2020 - medrxiv.org
Objective We aim to determine the impact of steroid use in COVID-19 pneumonia in-hospital
mortality. Design We performed a single-centre retrospective cohort study. Setting A …

Association of convalescent plasma treatment with clinical status in patients hospitalized with COVID-19: a meta-analysis

…, BJA Rijnders, C Rokx, A Sancho-Lopez… - JAMA Network …, 2022 - jamanetwork.com
… Dr Sancho-Lopez reported receiving personal fees from Bayer, Novartis, Merck, Boehringer
Ingelheim, Lilly, GSK, and Incyte outside the submitted work. Dr Yoon reported receiving …

[HTML][HTML] Clinical research and drug regulation in the challenging times of individualized therapies: A pivotal role of Clinical Pharmacology

A Gómez-Outes, A Sancho-López, AJC Sansuan… - Pharmacological …, 2024 - Elsevier
Since the 1980s, medical specialists in Clinical Pharmacology have been playing a crucial
role in the development of drug regulation in Spain. In this article we report on the activities …

[HTML][HTML] Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol …

…, A Ramos Martínez, A Sancho López… - Trials, 2020 - Springer
Objectives In some patients, acute, life-threatening respiratory injury produced by viruses such
as SARS-CoV and other viral pneumonia are associated with an over-exuberant cytokine …

The right time for steroids in COVID-19

…, E Múñez-Rubio, A Sancho-López… - Clinical Infectious …, 2021 - academic.oup.com
To the Editor—We have read with interest the work by Fadel et al [1] who describe a beneficial
effect of early steroid treatment in patients with moderate to severe coronavirus disease …

[HTML][HTML] Síndrome de trombosis con trombocitopenia asociado a vacunas de adenovirus frente a la COVID-19: Epidemiología y presentación clínica de la serie …

…, L Quiroga-González, GE Rivas, A Sancho-López… - Neurología, 2022 - Elsevier
Introducción Se describen las características epidemiológicas y clínicas de los casos de
síndrome de trombosis con trombocitopenia (STT) notificados en España. Métodos Se …

Thrombosis with Thrombocytopenia Syndrome following adenovirus vector-based vaccines to prevent COVID-19: epidemiology and clinical presentation in Spain

…, GE Rivas, A Sancho-López… - Neurologia …, 2022 - europepmc.org
Background We describe the epidemiological and clinical characteristics of thrombosis with
thrombocytopenia syndrome (TTS) cases reported in Spain. Methods We included all …